Southeast Asia digital economy weekly newsletter and its monthly research reports. Angus is also the founder of CrossASEAN Research and publishes on SMARTKARMA.
Read More
Excerpt: “A majority of the investments they’ve made is losing money, and whether that turns around or not over the long term we don’t know,” said Kirk Boodry, an analyst at Redex Research who publishes on Smartkarma.
Jeong Lee, Takahiko Hyuga • (Opens in a new window) ⧉
Are you a Professional Journalist?
The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.
money, and whether that turns around or not over the long term we don’t know,” said Kirk Boodry, an analyst at Redex Research who publishes on SMARTKARMA. The key for SoftBank lies with Arm’s IPO, which was once said could be valued at $60 billion and hold the ability to jump
Excerpt: Mio Kato, a Lightstream Research analyst, and author for Smartkarma, told AFP that Toyota was likely to maintain its position as the top seller.
Rohit Kulkarni • (Opens in a new window) ⧉
Are you a Professional Journalist?
The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.
Excerpt: … start to scrutinise their exposure to a business empire that sprawls from ports to green energy.They have obviously found the investors but concerns of Hindenburg Research have not been addressed,” said Brian Freitas, an analyst at Smartkarma.“The …
Head Topics – News • (Opens in a new window) ⧉
Are you a Professional Journalist?
The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.
Excerpt: … of many Indian conglomerates which have followed in Adani’s footsteps funding rapid expansions in infrastructure through large amounts of debt, Steno Research, a Denmark-based research house, wrote in a Friday report published on the Smartkarma …
Huileng Tan • (Opens in a new window) ⧉
Are you a Professional Journalist?
The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.
in a Friday report published on the SMARTKARMA research platform. It doesn t help that the drama surrounding the Adani Group comes at an inopportune time — that is, just as
Excerpt: … shaken by the turmoil.All 15 dollar debt securities of the group also advanced on Friday.They have obviously found the investors but concerns of Hindenburg Research have not been addressed,” said Brian Freitas, an analyst at Smartkarma.Still, there …
Head Topics – News • (Opens in a new window) ⧉
Are you a Professional Journalist?
The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.
Excerpt: Google News Opening https://www.smartkarma.com/home/daily-briefs/daily-brief-health-care-dentium-co-ltd-new-ruipeng-pet-group-takeda-pharmaceutical-china-shineway-pharmaceutical-aft-pharmaceuticals-paradigm-biopharmaceuticals-and-more/
google.com • (Opens in a new window) ⧉
Are you a Professional Journalist?
The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.
Excerpt: … has repeatedly denied the allegations and called the report “bogus”, and threatened legal action.They have obviously found the investors but concerns of Hindenburg Research have not been addressed,” said Brian Freitas, an analyst at Smartkarma.Other …
Head Topics – News • (Opens in a new window) ⧉
Are you a Professional Journalist?
The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.